COI
TEVA icon

Connable Office Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Connable Office Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
31,114
-515
-2% -$17.2K 0.09% 90
2026
Q1 		$953K Buy
+31,629
New +$1.02M 0.09% 90
2017
Q1 		– Sell
-29,640
Closed -$1.07M – 207
2016
Q4 		$1.07M Hold
29,640
– – 0.25% 80
2016
Q3 		$1.36M Buy
29,640
+22,230
+300% +$1.16M 0.33% 72
2016
Q2 		$372K Buy
7,410
+415
+6% +$22.1K 0.1% 98
2016
Q1 		$374K Buy
6,995
+1,235
+21% +$72.5K 0.1% 96
2015
Q4 		$378K Sell
5,760
-4,918
-46% -$304K 0.11% 104
2015
Q3 		$603K Sell
10,678
-2,568
-19% -$167K 0.18% 79
2015
Q2 		$783K Hold
13,246
– – 0.21% 69
2015
Q1 		$825K Buy
13,246
+855
+7% +$49.7K 0.21% 69
2014
Q4 		$713K Sell
12,391
-107
-0.9% -$5.96K 0.19% 73
2014
Q3 		$672K Buy
12,498
+875
+8% +$46.4K 0.18% 75
2014
Q2 		$609K Buy
11,623
+7,595
+189% +$388K 0.16% 79
2014
Q1 		$213K Buy
+4,028
New +$186K 0.06% 198

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Connable Office Inc's TEVA Position: Q2 2026 in Review

Connable Office Inc reduced its Teva Pharmaceuticals (TEVA) stake by 1.6% in Q2 2026, selling an estimated $17.2K and leaving 31,114 shares worth $1.05M. The position accounts for 0.09% of the portfolio, ranked #90.

Connable Office Inc first reported a position in TEVA in Q1 2014 and has held it in 14 quarters since. The position peaked at $1.36M in Q3 2016. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Connable Office Inc held 31,114 shares of Teva Pharmaceuticals worth $1.05M as of Q2 2026.
  • Connable Office Inc sold 515 Teva Pharmaceuticals shares in Q2 2026, an estimated $17.2K.
  • Teva Pharmaceuticals made up 0.09% of Connable Office Inc's portfolio in Q2 2026, its #90 holding.
  • Connable Office Inc first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 14 quarters since.
  • Connable Office Inc's Teva Pharmaceuticals position peaked at $1.36M in Q3 2016.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Connable Office Inc's 13F filing for Q2 2026, filed 3 Aug 2026.